HTG Molecular Diagnostics to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference
HTG Molecular Diagnostics (Nasdaq: HTGM) announces participation in the H.C. Wainwright’s 23rd Annual Global Investment Conference from September 13-15, 2021. Management will present at 7:00 a.m. ET on September 13 and will be available for one-on-one meetings. This event underscores HTG's commitment to advancing precision medicine through its proprietary HTG EdgeSeq technology, which facilitates complex molecular profiling from both solid and liquid samples. Further details on the webcast and meeting requests can be found in the release.
- None.
- None.
TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that company management will participate in H.C. Wainwright’s 23rd Annual Global Investment Conference, being held September 13th – 15th, 2021.
Details for the presentation are below:
| Date: | 7:00 a.m. ET |
| Time: | Monday, September 13th, 2021 |
| Webcast: | https://journey.ct.events/view/36113800-95ac-4c91-b29a-d6ec60e0fddf |
Management will also be available for 1x1 meetings. If you would like to request a meeting, please email meetings@hcwco.com.
About HTG:
HTG is focused on NGS-based molecular profiling. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. Its mission is to empower precision medicine. To learn more, visit www.htgmolecular.com.
Contact:
Ashley Robinson
Phone: (617) 430-7577
Email: arr@lifesciadvisors.com
FAQ
What event will HTG Molecular Diagnostics participate in September 2021?
What is the date and time of HTG's presentation at the conference?
How can I access the webcast for HTG's presentation?
How can I request a 1x1 meeting with HTG management during the conference?
What technology does HTG use for molecular profiling?
